Search results for "SAGE"

showing 10 items of 1373 documents

Oral Solid Dosage Form Disintegration Testing — The Forgotten Test

2014

Since its inception in the 1930s, disintegration testing has become an important quality control (QC) test in pharmaceutical industry, and disintegration test procedures for various dosage forms have been described by the different pharmacopoeias, with harmonization among them still not quite complete. However, because of the fact that complete disintegration does not necessarily imply complete dissolution, much more research has been focused on dissolution rather than on disintegration testing. Nevertheless, owing to its simplicity, disintegration testing seems to be an attractive replacement to dissolution testing as recognized by the International Conference on Harmonization guidelines, …

Dosage FormsSolubilityRisk analysis (engineering)Test proceduresChemistry PharmaceuticalPharmaceutical ScienceDissolution testingBusinessDosage formIntestinal absorptionBiopharmaceuticsTest (assessment)Journal of Pharmaceutical Sciences
researchProduct

Doux paysages du Doubs

1994

L'eau est partout dans le paysage. Elle intervient comme agent d'érosion : géologues et géomorphologues savent expliquer le rôle prépondérant qu'elle prend dans le façonnement du relief. Elle s'y manifeste aussi comme élément de construction visuelle. Enfin, les sociétés humaines ont conquis les paysages et les ont aménagés pour en faire le support de leurs activités.

Doubs[SHS.GEO] Humanities and Social Sciences/Geographypaysages[SHS.GEO]Humanities and Social Sciences/Geography[ SHS.GEO ] Humanities and Social Sciences/Geography
researchProduct

Infrastructures agroécologiques en droit

2017

International audience; Les infrastructures agroécologiques (IAE) sont une notion récente désignant des éléments naturels, culturels et paysagers, tels les mares, les landes, les haies, les talus, les fossés, les arbres, les bosquets, les bandes enherbées le long des cours d’eau, les murets de pierre ou encore les terrasses. Pendant des siècles, ces milieux physiques sont passés inaperçus pour le droit. Attachés au foncier, ils n’en constituaient qu’un accessoire sommé de suivre le régime juridique du principal. Ces infrastructures étaient sous l’entière maîtrise du propriétaire immobilier pouvant, à sa guise, les créer ou les faire disparaître. Leur statut a cependant c…

Droit rural[ SDE.BE ] Environmental Sciences/Biodiversity and Ecology[SHS.DROIT] Humanities and Social Sciences/Law[ SDV.AEN ] Life Sciences [q-bio]/Food and Nutritionagroécologie[ SHS.ENVIR ] Humanities and Social Sciences/Environmental studies[SDE.ES]Environmental Sciences/Environmental and Society[ SHS.DROIT ] Humanities and Social Sciences/Law[SDE.BE] Environmental Sciences/Biodiversity and Ecology[SDV.AEN] Life Sciences [q-bio]/Food and Nutrition[SHS.DROIT]Humanities and Social Sciences/Law[SHS.ENVIR] Humanities and Social Sciences/Environmental studies[SHS.ENVIR]Humanities and Social Sciences/Environmental studiesexploitation agricole[SDE.ES] Environmental Sciences/Environmental and Societyruralpaysage[SDE.BE]Environmental Sciences/Biodiversity and Ecologyinfrastructurespatrimoine naturel[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition[ SDE.ES ] Environmental Sciences/Environmental and Societyintérêt écologique
researchProduct

Biowaiver monographs for immediate-release solid oral dosage forms: Zidovudine (azidothymidine).

2012

Literature data on the properties of zidovudine relevant to waiver of in vivo bioequivalence (BE) testing requirements for the approval of immediate-release (IR) solid oral dosage forms containing zidovudine alone or in combination with other active pharmaceutical ingredients (APIs) are reviewed. Solubility, dissolution, and permeability data for zidovudine, along with its dosing schedule, therapeutic index and pharmacokinetic properties, and reports related to BE/bioavailability were all taken into consideration. Data for solubility and permeability suggest that zidovudine belongs to Class I according to the Biopharmaceutics Classification System. Also, zidovudine is not a narrow therapeut…

DrugAnti-HIV Agentsmedia_common.quotation_subjectPharmaceutical ScienceExcipientAdministration OralHIV InfectionsPharmacologyBioequivalenceDosage formPermeabilityCell LineExcipientsZidovudineDogsPharmacokineticsBIOEQUIVALÊNCIAMedicineAnimalsHumansmedia_commonActive ingredientbusiness.industryBiopharmaceutics Classification SystemSolubilityTherapeutic EquivalencyCaco-2 CellsbusinessZidovudinemedicine.drugJournal of pharmaceutical sciences
researchProduct

Controlled transdermal iontophoresis by ion-exchange fiber

2000

The objective of this study was to assess the transdermal delivery of drugs using iontophoresis with cation- and anion-exchange fibers as controlled drug delivery vehicles. Complexation of charged model drugs with the ion-exchange fibers was studied as a method to achieve controlled transdermal drug delivery. Drug release from the cation-exchange fiber into a physiological saline was dependent on the lipophilicity of the drug. The release rates of lipophilic tacrine and propranolol were significantly slower than that of hydrophilic nadolol. Permeation of tacrine across the skin was directly related to the iontophoretic current density and drug concentration used. Anion-exchange fiber was te…

DrugChemical PhenomenaSkin Absorptionmedia_common.quotation_subjectPharmaceutical Science02 engineering and technologyIn Vitro TechniquesPharmacologyAdministration Cutaneous030226 pharmacology & pharmacyDosage form03 medical and health scienceschemistry.chemical_compound0302 clinical medicineHumansFiberElectrodesSodium salicylateTransdermalmedia_commonMineral FibersActive ingredientChromatographyIontophoresisChemistry PhysicalIontophoresisModels Theoretical021001 nanoscience & nanotechnologyIon ExchangechemistryDrug deliveryTacrine0210 nano-technologyAlgorithmsJournal of Controlled Release
researchProduct

Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Piroxicam

2014

ABSTRACT Literature and experimental data relevant to the decision to allow a waiver of in vivo bioequivalence (BE) testing for the approval of immediate release (IR) solid oral dosage forms containing piroxicam in the free acid form are reviewed. Piroxicam solubility and permeability, its therapeutic use and therapeutic index, pharmacokinetic properties, data related to the possibility of excipient interactions and reported BE/bioavailability (BA), and corresponding dissolution data are taken into consideration. The available data suggest that according to the current biopharmaceutics classification system (BCS) and all current guidances, piroxicam would be assigned to BCS Class II. The ex…

DrugChemistry Pharmaceuticalmedia_common.quotation_subjectBiological AvailabilityPharmaceutical ScienceExcipientBioequivalencePharmacologyPiroxicamDosage formBiopharmaceuticsArthritis RheumatoidExcipientsFood-Drug InteractionsPiroxicamPharmacokineticsmedicineAnimalsHumansTissue Distributionmedia_commonChemistryAnti-Inflammatory Agents Non-SteroidalStereoisomerismBiopharmaceutics Classification SystemRatsBioavailabilityIntestinal AbsorptionSolubilityTherapeutic EquivalencyCaco-2 CellsHalf-Lifemedicine.drugJournal of Pharmaceutical Sciences
researchProduct

Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Proguanil Hydrochloride

2018

Abstract Literature data relevant to the decision to waive in vivo bioequivalence testing for the approval of generic immediate release solid oral dosage forms of proguanil hydrochloride are reviewed. To elucidate the Biopharmaceutics Classification System (BCS) classification, experimental solubility and dissolution studies were also carried out. The antimalarial proguanil hydrochloride, effective via the parent compound proguanil and the metabolite cycloguanil, is not considered to be a narrow therapeutic index drug. Proguanil hydrochloride salt was shown to be highly soluble according to the U.S. Food and Drug Administration, World Health Organization, and European Medicines Agency guide…

DrugCycloguanilProguanilmedia_common.quotation_subjectProguanil HydrochlorideAdministration OralPharmaceutical SciencePharmacologyBioequivalence030226 pharmacology & pharmacyDosage formExcipientsAntimalarials03 medical and health sciences0302 clinical medicineparasitic diseasesAnimalsHumansMedicineRegulatory sciencemedia_commonDosage Formsbusiness.industryBiopharmaceutics Classification SystemMalariaProguanilSolubilityTherapeutic Equivalency030220 oncology & carcinogenesisbusinessmedicine.drugJournal of Pharmaceutical Sciences
researchProduct

Biowaiver monographs for immediate release solid oral dosage forms: efavirenz.

2013

Literature data pertaining to the decision to allow a waiver of in vivo bioequiv- alence testing for the approval of immediate-release (IR) solid oral dosage forms containing efavirenz as the only active pharmaceutical ingredient (API) are reviewed. Because of lack of conclusive data about efavirenz's permeability and its failure to comply with the "high solu- bility" criteria according to the Biopharmaceutics Classification System (BCS), the API can be classified as BCS Class II/IV. In line with the solubility characteristics, the innovator product does not meet the dissolution criteria for a "rapidly dissolving product." Furthermore, product variations containing commonly used excipients …

DrugCyclopropanesEfavirenzTime FactorsAnti-HIV Agentsmedia_common.quotation_subjectChemistry PharmaceuticalPharmaceutical ScienceAdministration OralBiological AvailabilityPharmacologyDosage formBiopharmaceuticschemistry.chemical_compoundInnovatorAnimalsHumansRegulatory scienceImmediate releasemedia_commonActive ingredientChemistryBiopharmaceutics Classification SystemBenzoxazinesSolubilityTherapeutic EquivalencyAlkynesJournal of pharmaceutical sciences
researchProduct

Effect of thickener on disintegration, dissolution and permeability of common drug products for elderly patients

2019

Dysphagia is a very common problem suffered by elderly patients. The use of thickeners during administration in these patients helps to prevent difficulties with swallowing larger solid dosage forms. However, there are several indications when the thickeners may influence disintegration and dissolution processes of solid dosage forms, potentially affecting therapeutic efficacy. In this paper the effects of a commonly used thickener on tablet disintegration, dissolution and subsequent absorption of 6 formulated drugs frequently used in elderly patients (Aspirin, Atenolol, Acenocumarol, Candesartan, Ramipril and Valsartan) in two different administration conditions (intact tablet and crushed …

DrugDrug Compoundingmedia_common.quotation_subjectPharmaceutical Science02 engineering and technologyPharmacology030226 pharmacology & pharmacyPermeabilityDosage form03 medical and health sciences0302 clinical medicinemedicineAnimalsHumansIn patientDissolution testingRats WistarDissolutionAgedmedia_commonViscosityChemistryGeneral Medicine021001 nanoscience & nanotechnologyAtenololRatsDrug LiberationSolubilityPermeability (electromagnetism)Deglutition Disorders0210 nano-technologyTabletsBiotechnologymedicine.drugEuropean Journal of Pharmaceutics and Biopharmaceutics
researchProduct

Biowaiver Monographs for Immediate-Release Solid Oral Dosage Forms: Enalapril

2018

Literature data relevant to the decision to allow a waiver of in vivo bioequivalence testing for the marketing authorization of immediate-release, solid oral dosage forms containing enalapril maleate are reviewed. Enalapril, a prodrug, is hydrolyzed by carboxylesterases to the active angiotensin-converting enzyme inhibitor enalaprilat. Enalapril as the maleate salt is shown to be highly soluble, but only 60%-70% of an orally administered dose of enalapril is absorbed from the gastrointestinal tract into the enterocytes. Consequently, enalapril maleate is a Biopharmaceutics Classification System class III substance. Because in situ conversion of the maleate salt to the sodium salt is sometim…

DrugEnalaprilatmedia_common.quotation_subjectAdministration OralPharmaceutical ScienceAngiotensin-Converting Enzyme InhibitorsBioequivalencePharmacology030226 pharmacology & pharmacyPermeabilityDosage form03 medical and health sciences0302 clinical medicineDrug StabilityEnalaprilmedicineHumansProdrugsEnalaprilmedia_commonChromatographyChemistryProdrugBiopharmaceutics Classification SystemIntestinal AbsorptionSolubilityTherapeutic EquivalencyEnalapril Maleate030220 oncology & carcinogenesisTabletsmedicine.drugJournal of Pharmaceutical Sciences
researchProduct